Open Access iconOpen Access

ARTICLE

crossmark

Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients

JUAN SHEN1,#, WEIYU ZHANG2,3,#, QINQIN JIN2,3,#, FUYU GONG4,#, HEPING ZHANG5, HONGLIANG XU5, JIEJIE LI2,3, HUI YAO2,3, XIYA JIANG2,3, YINTING YANG2,3, LIN HONG2,3, JIE MEI2,3, YANG SONG6,*, SHUGUANG ZHOU2,3,7,*

1 School of Big Data and Artificial Intelligence, Anhui Xinhua University, Hefei, 230088, China
2 Department of Gynecology and Obstetrics, Maternity and Child Healthcare Hospital Affiliated to Anhui Medical University, Anhui Province Maternity and Child Healthcare Hospital, Hefei, 230001, China
3 Department of Gynecology and Obstetrics, The Fifth Clinical College of Anhui Medical University, Hefei, 230032, China
4 Departments of Breast Surgery, Fuyang Women and Children’s Hospital, Fuyang, 236000, China
5 Departments of Pathology, Anhui Province Maternity and Child Health Hospital, Hefei, 230001, China
6 Department of Pain, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China
7 Department of Gynecology and Obstetrics, Linquan Maternity and Child Healthcare Hospital, Fuyang, 236400, China

* Corresponding Authors: YANG SONG. Email: email; SHUGUANG ZHOU. Email: email
# These authors contributed equally

TSP_OR_30887.pdf

  • 966

    View

  • 212

    Download

  • 0

    Like

Share Link